Development of a novel blood-sparing agent in cardiac surgery: do we need another agent?
Publication
, Other
Faraoni, D; Levy, JH
Published in: Anesth Analg
July 2014
Duke Scholars
Published In
Anesth Analg
DOI
EISSN
1526-7598
Publication Date
July 2014
Volume
119
Issue
1
Start / End Page
11 / 12
Location
United States
Related Subject Headings
- Serine Proteinase Inhibitors
- Male
- Humans
- Female
- Coronary Artery Bypass
- Cardiopulmonary Bypass
- Antifibrinolytic Agents
- Anesthesiology
- 3202 Clinical sciences
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Faraoni, D., & Levy, J. H. (2014). Development of a novel blood-sparing agent in cardiac surgery: do we need another agent? Anesth Analg. United States. https://doi.org/10.1213/ANE.0000000000000225
Faraoni, David, and Jerrold H. Levy. “Development of a novel blood-sparing agent in cardiac surgery: do we need another agent?” Anesth Analg, July 2014. https://doi.org/10.1213/ANE.0000000000000225.
Faraoni D, Levy JH. Development of a novel blood-sparing agent in cardiac surgery: do we need another agent? Vol. 119, Anesth Analg. 2014. p. 11–2.
Faraoni, David, and Jerrold H. Levy. “Development of a novel blood-sparing agent in cardiac surgery: do we need another agent?” Anesth Analg, vol. 119, no. 1, July 2014, pp. 11–12. Pubmed, doi:10.1213/ANE.0000000000000225.
Faraoni D, Levy JH. Development of a novel blood-sparing agent in cardiac surgery: do we need another agent? Anesth Analg. 2014. p. 11–12.
Published In
Anesth Analg
DOI
EISSN
1526-7598
Publication Date
July 2014
Volume
119
Issue
1
Start / End Page
11 / 12
Location
United States
Related Subject Headings
- Serine Proteinase Inhibitors
- Male
- Humans
- Female
- Coronary Artery Bypass
- Cardiopulmonary Bypass
- Antifibrinolytic Agents
- Anesthesiology
- 3202 Clinical sciences
- 1109 Neurosciences